Percutaneous approach to a stent-based ventricle to coronary vein bypass (venous VPASS™): comparison to catheter-based selective pressure-regulated retro-infusion of the coronary vein
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: European Heart Journal, 26, 12, S. 1228-1234
- Ereignis
-
Veröffentlichung
- (wo)
-
Augsburg
- (wer)
-
Universität Augsburg
- (wann)
-
2005
- Ereignis
-
Veröffentlichung
- (wer)
-
Oxford University Press (OUP)
- (wann)
-
2005
- Urheber
-
Raake, Philip
Hinkel, Rabea
Kupatt, Christian
Brühl, Marie-Luise von
Beller, Sabrina
Andrees, Martin
Vicol, Calin
Boekstegers, Peter
- DOI
-
10.1093/eurheartj/ehi136
- URN
-
urn:nbn:de:bvb:384-opus4-965644
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:36 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Raake, Philip
- Hinkel, Rabea
- Kupatt, Christian
- Brühl, Marie-Luise von
- Beller, Sabrina
- Andrees, Martin
- Vicol, Calin
- Boekstegers, Peter
- Universität Augsburg
- Oxford University Press (OUP)
Entstanden
- 2005
Ähnliche Objekte (12)
1081-61 Arterial retroperfusion by a percutaneous stent-based ventricle to coronary vein bypass (VVPASS™)
Therapeutische Angiogenese bei chronischer Myokardischämie-Applikation von FGF-2 mittels selektiver druckregulierter Retroinfusion im tierexperimentellen Modell am Schwein
Therapeutische Angiogenese bei chronischer Myokardischämie-Applikation von FGF-2 mittels selektiver druckregulierter Retroinfusion im tierexperimentellen Modell am Schwein
Therapeutische Angiogenese bei chronischer Myokardischämie-Applikation von FGF-2 mittels selektiver druckregulierter Retroinfusion im tierexperimentellen Modell am Schwein
Intraoperative model to flowmetry measurement from coronary-coronary saphenous vein graft bypass
1079-85 Adjunctive treatment with a stent-based ventricle to coronary artery bypass (VSTENT™) in patients with multivessel disease undergoing coronary artery bypass surgery (ADVANTAGE)
Adjunctive treatment with a stent-based ventricle to coronary artery bypass (VSTENT) in patients with multivessel coronary artery disease undergoing bypass surgery (ADVANTAGE): pilot phase [Abstract]
Amplifying effects of Relaxin by overexpression of its receptor
First clinical experience with the VSTENT: a device for direct left ventricle-to-coronary artery bypass
Hemopericardium Due to Idiopathic Coronary Artery Rupture Treated with Saphenous Vein Patch Plasty
Selective pressure-regulated retroinfusion of fibroblast growth factor-2 into the coronary vein enhances regional myocardial blood flow and function in pigs with chronic myocardial ischemia
The clinical application of microincision vein harvesting of the great saphenous vein in coronary artery bypass grafting
1081-61 Arterial retroperfusion by a percutaneous stent-based ventricle to coronary vein bypass (VVPASS™)
Therapeutische Angiogenese bei chronischer Myokardischämie-Applikation von FGF-2 mittels selektiver druckregulierter Retroinfusion im tierexperimentellen Modell am Schwein
Therapeutische Angiogenese bei chronischer Myokardischämie-Applikation von FGF-2 mittels selektiver druckregulierter Retroinfusion im tierexperimentellen Modell am Schwein
Therapeutische Angiogenese bei chronischer Myokardischämie-Applikation von FGF-2 mittels selektiver druckregulierter Retroinfusion im tierexperimentellen Modell am Schwein
Intraoperative model to flowmetry measurement from coronary-coronary saphenous vein graft bypass
1079-85 Adjunctive treatment with a stent-based ventricle to coronary artery bypass (VSTENT™) in patients with multivessel disease undergoing coronary artery bypass surgery (ADVANTAGE)
Adjunctive treatment with a stent-based ventricle to coronary artery bypass (VSTENT) in patients with multivessel coronary artery disease undergoing bypass surgery (ADVANTAGE): pilot phase [Abstract]
Amplifying effects of Relaxin by overexpression of its receptor
First clinical experience with the VSTENT: a device for direct left ventricle-to-coronary artery bypass
Hemopericardium Due to Idiopathic Coronary Artery Rupture Treated with Saphenous Vein Patch Plasty
Selective pressure-regulated retroinfusion of fibroblast growth factor-2 into the coronary vein enhances regional myocardial blood flow and function in pigs with chronic myocardial ischemia
The clinical application of microincision vein harvesting of the great saphenous vein in coronary artery bypass grafting
1081-61 Arterial retroperfusion by a percutaneous stent-based ventricle to coronary vein bypass (VVPASS™)
Therapeutische Angiogenese bei chronischer Myokardischämie-Applikation von FGF-2 mittels selektiver druckregulierter Retroinfusion im tierexperimentellen Modell am Schwein
Therapeutische Angiogenese bei chronischer Myokardischämie-Applikation von FGF-2 mittels selektiver druckregulierter Retroinfusion im tierexperimentellen Modell am Schwein
Therapeutische Angiogenese bei chronischer Myokardischämie-Applikation von FGF-2 mittels selektiver druckregulierter Retroinfusion im tierexperimentellen Modell am Schwein
Intraoperative model to flowmetry measurement from coronary-coronary saphenous vein graft bypass
1079-85 Adjunctive treatment with a stent-based ventricle to coronary artery bypass (VSTENT™) in patients with multivessel disease undergoing coronary artery bypass surgery (ADVANTAGE)
Adjunctive treatment with a stent-based ventricle to coronary artery bypass (VSTENT) in patients with multivessel coronary artery disease undergoing bypass surgery (ADVANTAGE): pilot phase [Abstract]
Amplifying effects of Relaxin by overexpression of its receptor
First clinical experience with the VSTENT: a device for direct left ventricle-to-coronary artery bypass
Hemopericardium Due to Idiopathic Coronary Artery Rupture Treated with Saphenous Vein Patch Plasty
Selective pressure-regulated retroinfusion of fibroblast growth factor-2 into the coronary vein enhances regional myocardial blood flow and function in pigs with chronic myocardial ischemia